Skip to content
★ Sign in to follow
CD

Carlos David Freitas De Sousa

ImmunicumMendus ABImmunicum AB
Total declarations
16
Companies
3
▲ Purchases (15 ops.)
€72k
▼ Sales (0 ops.)
—

Latest filing published 30 Aug 2019 for Mendus AB, €7,952.

Filing timeline

BuySale
Carlos David Freitas De Sousa

Insider track record

Disclosed buys
15
Disclosed sells
0
Signal history

Closed purchases

Market purchases
15
Positive at T+90
60%
Median T+90
+7.2%

Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 30 Aug 2019 · 2627 days ago · €7,952
    +36.3%
    Entry SEK 134.66 · Close at T+365 SEK 183.57
  • Filed 06 Mar 2019 · 2804 days ago · €2,695
    -5.0%
    Entry SEK 137.24 · Close at T+365 SEK 130.42
  • Filed 16 Jan 2018 · 3218 days ago · €4,417
    +23.0%
    Entry SEK 136.46 · Close at T+365 SEK 167.82

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Carlos David Freitas De Sousa: trading record in brief

Carlos David Freitas De Sousa has filed trades across 3 companies (mainly through Finansinspektionen), most often in Mendus AB, Immunicum AB and Immunicum. Between 8 December 2016 and 29 August 2019, the trades on record add up to 16 filings.

On the market, this insider has only ever bought: 15 purchases, €72k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2019 alone, the filings show 4 purchases and no sales.

In size, the median ticket on the buying side is €2,695. 4 out of 14 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Looking at 5 purchases old enough to measure, the stock rose over the following 90 days in 60% of cases; the median change was +7.2%. They describe history only and say nothing certain about the share price ahead.

The latest filing, published on 30 August 2019, reports an open-market purchase of €7,952 in Mendus AB. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 1 day. Under the Market Abuse Regulation, managers have three business days to notify their trades. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Carlos David Freitas De Sousa

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations16 total
  • ▲
    Managing DirectorExecutivesMendus AB
    86,000 SEK23FI-SE
    10,000 shares@ SEK 8.605.4% of flowAktieISIN SE0005003654FI:csv-283b9178cff04d3dae7f
    Canonical exit: 27 Nov 2019 (T+90)
  • ▲
    Managing DirectorExecutivesMendus AB
    240,100 SEK0FI-SE
    691,931 shares@ SEK 0.34715.1% of flowTeckningsoptionFI:csv-01d3649160019693870b
    Canonical exit: 25 Aug 2019 (T+90)
  • ▲
    Managing DirectorExecutivesMendus AB
    28,375 SEK22FI-SE
    3,685 shares@ SEK 7.701.8% of flowAktieISIN SE0005003654FI:csv-9368f64ee9ec802a8aaa
    Canonical exit: 4 Jun 2019 (T+90)
  • ▲
    Managing DirectorExecutivesMendus AB
    16,864 SEK22FI-SE
    2,193 shares@ SEK 7.691.1% of flowAktieISIN SE0005003654FI:csv-48f3a998083d2c029be4
    Canonical exit: 4 Jun 2019 (T+90)
  • ●
    Managing DirectorExecutivesMendus AB
    483,582 SEK0FI-SE
    56,892 shares@ SEK 8.5031.6% of flowBTA (betald tecknad aktie)ISIN SE0011973833FI:csv-6e6392a85921e81a2d02
  • ▲
    VDExecutivesImmunicum AB
    68,900 SEK39FI-SE
    10,000 shares@ SEK 6.8949.8% of flowISIN SE0005003654FI:csv-d038806062a3477558d3
    Canonical exit: 21 May 2018 (T+90)
  • ▲
    VDExecutivesImmunicum AB
    70,000 SEK39FI-SE
    10,000 shares@ SEK 7.0050.2% of flowISIN SE0005003654FI:csv-5ec98a4739336d5f25fd
    Canonical exit: 22 May 2018 (T+90)
  • ▲
    Managing DirectorExecutivesImmunicum AB
    7,128 SEK23FI-SE
    1,056 shares@ SEK 6.7510.5% of flowISIN SE0005003654FI:csv-f7bf1013e2242529b05e
    Canonical exit: 20 May 2018 (T+90)
  • ▲
    Managing DirectorExecutivesImmunicum AB
    50,205 SEK29FI-SE
    7,394 shares@ SEK 6.7974.0% of flowISIN SE0005003654FI:csv-15129a00850e0c097e6f
    Canonical exit: 20 May 2018 (T+90)
  • ▲
    Managing DirectorExecutivesImmunicum AB
    10,509 SEK24FI-SE
    1,550 shares@ SEK 6.7815.5% of flowISIN SE0005003654FI:csv-7ddba296357e5b0b0aa1
    Canonical exit: 20 May 2018 (T+90)
  • ▲
    Managing DirectorExecutivesMendus AB
    43,345 SEK40FI-SE
    6,337 shares@ SEK 6.843.0% of flowISIN SE0005003654FI:csv-12ed5e6147ecfc94945d
    Canonical exit: 15 Apr 2018 (T+90)
  • ▲
    Managing DirectorExecutivesMendus AB
    25,092 SEK40FI-SE
    3,663 shares@ SEK 6.851.7% of flowISIN SE0005003654FI:csv-83e8762129b863847e75
    Canonical exit: 15 Apr 2018 (T+90)
  • ▲
    Managing DirectorExecutivesImmunicum
    20,899 SEK24FI-SE
    933 shares@ SEK 22.4021.6% of flowISIN SE0005003654FI:csv-49bdc0c40251a52f252c
    Canonical exit: 9 Mar 2017 (T+90)
  • ▲
    Managing DirectorExecutivesImmunicum
    22,490 SEK24FI-SE
    1,000 shares@ SEK 22.4923.3% of flowISIN SE0005003654FI:csv-bd048f4055f485f11bdf
    Canonical exit: 9 Mar 2017 (T+90)
  • ▲
    Managing DirectorExecutivesImmunicum
    2,249 SEK22FI-SE
    100 shares@ SEK 22.492.3% of flowISIN SE0005003654FI:csv-a1b00cbc40809bf3fabb
    Canonical exit: 8 Mar 2017 (T+90)
  • ▲
    Managing DirectorExecutivesImmunicum
    49,880 SEK27FI-SE
    2,000 shares@ SEK 24.9452.8% of flowISIN SE0005003654FI:csv-b2125132aed3c41f86ae
    Canonical exit: 21 May 2017 (T+90)

16 of 16 declarations